Physician profile
Amanda Heisel
NPI 1073041760
$1,578.56
in general payments reported to CMS, 2019-2025
12 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $381 · 2022: $371 · 2023: $468 · 2024: $134 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $826.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $809.02 | 2021-2025 | Speedicath |
| Astellas Pharma US INC | $186.90 | 2021-2023 | Myrbetriq |
| C. R. Bard, INC. & Subsidiaries | $157.08 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Rochester Medical Corporation | $153.18 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $138.45 | 2023-2025 | Gemtesa |
| Ferring Pharmaceuticals INC. | $32.16 | 2025 | Adstiladrin |
| 180 Medical, INC. | $24.10 | 2021 | |
| Becton, Dickinson and Company | $20.00 | 2024 | Bard Urinary Drainage Bag |
| Teleflex LLC | $18.46 | 2023 | Urolift |
| Myriad Genetic Laboratories, INC. | $15.75 | 2021 | |
| Celgene Corporation | $11.76 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Heisel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.